CNSP
Cns Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$4.51
-0.04 (-0.88%)
Open$4.50
Previous Close$4.55
Day High$4.73
Day Low$4.34
52W High$44.57
52W Low$29.83
Volume—
Avg Volume467.1K
Market Cap2.80M
P/E Ratio22.43
EPS$1.67
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+845.9% upside
Current
$4.51
$4.51
Target
$42.66
$42.66
$27.73
$42.66 avg
$55.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 401.0K | 379.4K | 323.5K |
| Net Income | 137.9K | 129.6K | 106.9K |
| Profit Margin | 34.4% | 34.2% | 33.1% |
| EBITDA | 186.8K | 161.4K | 136.4K |
| Free Cash Flow | 134.0K | 130.1K | 98.1K |
| Rev Growth | +21.3% | -7.8% | +5.5% |
| Debt/Equity | 0.24 | 0.32 | 0.31 |
Dividend
Dividend Yield1.78%
Annual Dividend$0.67
Payout Ratio40.0%
Frequencyquarterly
Ex-DividendApr 10, 2026
Pay DateApr 29, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |